Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 7Lymphoid 7Plasma cell 4Myeloid 3Dermatologic 3Thoracic 1Sarcoma 1Other neoplasm 1Gynecologic 1Classical hematology 1CNS 1Breast 1

Conditions

Anemia, Refractory, with Excess of Blasts 8Myelodysplastic Syndromes 7Myeloproliferative Disorders 6Leukemia, Myelomonocytic, Chronic 6Leukemia, Myeloid, Acute 6Leukemia 6Congenital Abnormalities 6Anemia, Refractory 5Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myelomonocytic, Acute 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Multiple Myeloma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hodgkin Disease 2Anemia, Aplastic 2Waldenstrom Macroglobulinemia 1Thrombocytopenia 1Recurrence 1Primary Myelofibrosis 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

fludarabine phosphate 15Peripheral Blood Stem Cell Transplantation 12Whole-Body Irradiation 10Cyclophosphamide 10Mycophenolic Acid 8Antilymphocyte Serum 8Tacrolimus 7Busulfan 7Methotrexate 6Cyclosporine 6Melphalan 5Filgrastim 4Epoetin Alfa 4Therapeutics 3Sirolimus 3Darbepoetin alfa 3merphos 2Thiotepa 2Radiotherapy 2Methylprednisolone 2Etoposide 2Cord Blood Stem Cell Transplantation 2thymoglobulin 1sargramostim 1fludarabine 1ferrous sulfate 1ferric gluconate 1Vorinostat 1Valganciclovir 1Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Waldenstrom Macroglobulinemia × sargramostim × Classical hematology × Clear all
NCT00053989 2020-02-10

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

Roswell Park Cancer Institute

Phase 2 Completed
41 enrolled 13 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Congenital Abnormalities, Anemia, Aplastic, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Burkitt Lymphoma, Fanconi Anemia, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, B-Cell, Marginal Zone, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡